Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Comparing standard and low-dose continuous renal replacement therapy for acute kidney injury

Official title: A Randomized Controlled Study Investigating Standard Dose Continuous Renal Replacement Therapy (CRRT) Versus Low-Dose CRRT - The "Ketzerei" Trial

Run by Universität Münster · NCT06021288 · Data updated 2026-11-12

This study tests whether using a standard dose or a lower dose of a kidney treatment can help critically ill patients with acute kidney injury recover better.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment165 (estimated)
SponsorUniversität Münster
Academic / other
Locations2 sites (Münster and 1 other locations)
StatusRecruiting
StartedOctober 2, 2023
Main results expectedApril 30, 2025
Study endsJune 30, 2025
Registry record updatedNovember 27, 2024
Trial IDNCT06021288 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are critically ill adults aged 18 and older who are experiencing acute kidney injury and require continuous renal replacement therapy.

Probably not a fit

Patients who are chronically dependent on dialysis or have severe comorbid conditions such as chronic kidney disease or severe liver cirrhosis may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of standard dose continuous renal replacement therapy (CRRT) versus low-dose CRRT in critically ill patients suffering from acute kidney injury (AKI). The research aims to determine if a controlled level of azotaemia can lead to improved renal recovery in these patients. By enrolling adult patients who require CRRT, the study will assess the outcomes associated with different dosing strategies of CRRT. The findings could provide insights into optimizing treatment protocols for AKI in critical care settings.

Why it matters

Potential benefit: If successful, this study could lead to improved renal recovery rates in critically ill patients with acute kidney injury.

How similar studies have gone: While there is ongoing research in the area of CRRT, this specific comparison of standard versus low-dose CRRT is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients (age ≥18 years)
* Critically ill patients with AKI + in need of CRRT
* Written informed consent

Exclusion Criteria:

* Chronic dialysis dependency
* Chronic kidney disease with estimated glomerular filtration rate (eGFR) \<30 ml/min/1.73m²
* severe liver cirrhosis (Child-pugh C)
* severe acidosis (pH \< 7,20 at study enrolment)
* severe hyperkalaemia (\> 6mmol/l)
* Pregnancy or breastfeeding
* persons held in an institution by legal or official order
* Dependency on the investigator or center

Where it's running

  • University Hospital Münster
    Münster, Germany
    Recruiting
  • Universitätsklinikum Tübingen; Universitätsklinik für Anästhesiologie und Intensivmedizin
    Tübingen, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.